Table 3.

Summary of the secondary outcomes of the study

	Corticosteroids (n = 1117)	No corticosteroids (n = 463)	P value
Secondary outcomes
In-hospital mortality	428 (38.3%)	153 (33.0%)	0.05
Hospital LOS (days)
Overall	30 (21–46)	30 (18–46)	0.63
Survivors	37 (25–53)	38 (25–52)	0.70
Non-survivors	24 (15–33)	14 (9–24)	< 0.001
Ventilator-free days at 28 days	8.2 ± 9.2	7.5 ± 8.6	0.17
ICU LOS (days)
Overall	19 (11–31)	17 (10–31)	0.04
Survivors	18 (12–33)	20 (12–31)	0.82
Non-survivors	19 (11–29)	12 (6–23)	< 0.001
Ventilator-associated pneumonia	225 (20.1%)	90 (19.4%)	0.83

Ventilator-free days are expressed as mean and standard deviation using the Wilcoxon rank sum test with continuity correction. LOS (length of stay) is expressed as medians with interquartile ranges. Ventilator-associated pneumonia incidences are presented as numbers with percentages